4.4 Article

Mobile phone ownership, usage and readiness to use by patients in drug treatment

Journal

DRUG AND ALCOHOL DEPENDENCE
Volume 146, Issue -, Pages 111-115

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.drugalcdep.2014.11.001

Keywords

Mobile phone; Text-messaging; Drug treatment; Digital divide; Health

Funding

  1. South London & Maudsley (SLaM) NHS Foundation Trust
  2. National Addictions Centre, part of the Institute of Psychiatry, Psychology and Neuroscience (IOPPN)

Ask authors/readers for more resources

Background: Mobile phone based interventions using text-messages and smartphone apps demonstrate promise for enhancing the treatment of substance use disorders. However, there is limited evidence on the availability of mobile phones among people in substance use treatment, as well as usage patterns, contact preferences and willingness to use phone functions such as geo-location for treatment purposes. Method: A questionnaire was completed by 398 patients enrolled in four UK community drug treatment services. The majority (74%) reported being in treatment for heroin dependence, 9% for alcohol, 4% prescription drugs, 1% amphetamines, 1% club drugs and 1% cannabis. The remaining reported a combination of different drug categories. Results: Eighty-three percent of patients reported owning a mobile phone; 57% of phones were smart-phones and 72% of clients had a pay-as-you-go contract. Forty-six percent of phone owners changed their number in the previous year. Eighty-six percent were willing to be contacted by their treatment provider via mobile phone, although 46% thought the use of geo-location to be unacceptable. Conclusion: Mobile phones are widely available among individuals receiving community drug treatment and should be considered as a viable contact method by service providers, particularly text-messaging. However, patients may not have access to sophisticated features such as smartphone apps, and, up to date records of contact numbers must be frequently maintained. Developers need to be sensitive to issues of privacy and invasiveness around geo-location tracking and frequency of contact. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Clinical

Associations between primary care recorded cannabis use and mental ill health in the UK: a population-based retrospective cohort study using UK primary care data

Deepiksana Keerthy, Joht Singh Chandan, Juste Abramovaite, Krishna Margadhamane Gokhale, Siddhartha Bandyopadhyay, Ed Day, Steven Marwaha, Matthew R. Broome, Krishnarajah Nirantharakumar, Clara Humpston

Summary: This study investigates the relationship between cannabis exposure and the risks of mental illness diagnoses or treatment and finds that cannabis exposure is associated with an increased risk of developing mental health disorders.

PSYCHOLOGICAL MEDICINE (2023)

Editorial Material Urology & Nephrology

Short-term Healthy Lifestyle Intervention and Long-term Behavior Change After Kidney Transplantation: Findings From the CAVIAR Study

Kulli Kuningas, Joanne Driscoll, Reena Mair, Edward Day, Adnan Sharif

AMERICAN JOURNAL OF KIDNEY DISEASES (2023)

Article Public, Environmental & Occupational Health

Analysis of the UK Government's 10-Year Drugs Strategy-a resource for practitioners and policymakers

Adam Holland, Alex Stevens, Magdalena Harris, Dan Lewer, Harry Sumnall, Daniel Stewart, Eilish Gilvarry, Alice Wiseman, Joshua Howkins, Jim McManus, Gillian W. Shorter, James Nicholls, Jenny Scott, Kyla Thomas, Leila Reid, Edward Day, Jason Horsley, Fiona Measham, Maggie Rae, Kevin Fenton, Matthew Hickman

Summary: This article assesses the evidence-based and consistency of the UK Government's ten-year drugs strategy. While the strategy promises significant funding for drug treatment services and supports public health approaches, it also promotes unevidenced and harmful measures of punishment. The article argues for evidence-based measures to mitigate drug-related harm and calls for a more substantial re-orientation of UK drug policy.

JOURNAL OF PUBLIC HEALTH (2023)

Article Economics

The Cost-Effectiveness of Financial Incentives to Achieve Heroin Abstinence in Individuals With Heroin Use Disorder Starting New Treatment Episodes: A Cluster Randomized Trial-Based Economic Evaluation

James Shearer, Nicola Metrebian, Tim Weaver, Kimberley Goldsmith, John Strang, Stephen Pilling, Luke Mitcheson, Ed Day, John Dunn, Anthony Glasper, Shabana Akhtar, Jalpa Bajaria, Vikki Charles, Roopal Desai, Farjana Haque, Nicholas Little, Hortencia McKechnie, Franziska Mosler, Julian Mutz, Dilkushi Poovendran, Sarah Byford

Summary: This study conducted a cost-effectiveness analysis of two 12-week contingency management schedules targeting heroin abstinence or attendance at weekly keyworker appointments for opioid agonist treatment. The results showed that neither method was cost-effective over the 24-week follow-up period. However, the method targeting attendance at treatment was cost-effective over the 12-week treatment period. Rating: 7 out of 10.

VALUE IN HEALTH (2023)

Article Substance Abuse

Qualitative study of patients' decisions to initiate injectable depot buprenorphine for opioid use disorder: the role of information and other factors

Joanne Neale, Stephen Parkin, John Strang

Summary: This study explores individuals' decisions to initiate injectable depot buprenorphine based on the concept of the 'informed patient'. The findings show that participants' decisions were influenced by receiving sufficient information and trust in depot buprenorphine, dissatisfaction with current treatment, uncritical perceptions of depot buprenorphine, and limited access to the medication. Overall, participants felt they had enough information to decide on depot buprenorphine, but dissatisfaction with current treatment and limited availability hindered informed decision-making.

DRUGS-EDUCATION PREVENTION AND POLICY (2023)

Article Substance Abuse

How do patients feel during the first 72 h after initiating long-acting injectable buprenorphine? An embodied qualitative analysis

Joanne Neale, Stephen Parkin, John Strang

Summary: This study analyzed patients' experiences during the first 72 hours after initiating long-acting injectable buprenorphine treatment. Participants reported complex combinations of positive and negative feelings, including withdrawal symptoms, sleep problems, injection-site pain, fatigue, and nausea. However, they also reported improvements in somatic wellbeing, sleep, skin, appetite, and pleasure. Providing information about these effects can help prepare patients and improve medication adherence.

ADDICTION (2023)

Article Substance Abuse

Seasonal, weekly and other cyclical patterns in deaths due to drug poisoning in England and Wales

Dan Lewer, Thomas D. Brothers, Antonio Gasparrini, John Strang

Summary: The rate of drug poisoning deaths in England and Wales has been increasing annually since 2010. The study found seasonal and cyclical variations in these deaths, with peaks occurring in Spring and briefly at New Year. This suggests the involvement of external triggers.

ADDICTION (2023)

Article Substance Abuse

Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study

Dominic Oliver, Amir Englund, Edward Chesney, Lucy Chester, Jack Wilson, Simina Sovi, Stina Wigroth, John Hodsoll, John Strang, Robin M. Murray, Tom P. Freeman, Paolo Fusar-Poli, Philip McGuire

Summary: This study aimed to investigate the effects of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on attentional bias and explicit liking. The results showed that inhaled THC increased attentional bias towards cannabis, while CBD had no influence on this effect.

ADDICTION (2023)

Editorial Material Substance Abuse

How Addiction handles disagreements over potentially harmful terminology

Keith Humphreys, Rob Calder, John Marsden, Ed Day

ADDICTION (2023)

Article Gastroenterology & Hepatology

Behaviour regulation and the role of mental health in non-alcoholic fatty liver disease

E. Asquith, K. Bould, J. C. Catling, E. J. Day, A. Holt

Summary: This study aims to investigate factors influencing patients' adherence to treatment regimes for NAFLD. Novel areas of interest such as locus of control, behavioural regulation, and mental health measures were explored due to their connection to poor lifestyle choices and abnormal eating. The results showed significant differences among groups in cognitive restraint, uncontrolled eating, and SAPAS score (a measure of personality disorders). An association between personality disorders and NAFLD was identified.

BMC GASTROENTEROLOGY (2023)

Article Psychiatry

Identifying the most important research, policy and practice questions for substance use, problematic alcohol use and behavioural addictions in autism (SABA-A): A priority setting partnership

Julia M. A. Sinclair, Betul Aslan, Roberta Agabio, Amith Anilkumar, Mark Brosnan, Ed Day, Nicki A. Dowling, Chelsey Flood, Jon E. Grant, Robyn Halliday, Bjorn Hofvander, Leesa Howes, Rachel Moseley, Bronwyn Myers, Vincent O'Connor, Gabriel Shaya, Shane Thomas, Janine Robinson, Samuel R. Chamberlain

Summary: Autistic individuals are more prone to problematic alcohol and substance use compared to the general population. Research shows that around one in three autistic adults may have an alcohol or substance use disorder, while the evidence for behavioral addictions is less clear. Substance use and addictive behaviors may be used by autistic individuals as a way to cope with social anxiety and challenges. However, the lack of literature on the intersection between autism and these conditions hinders progress in health policy, research, and clinical practice.

COMPREHENSIVE PSYCHIATRY (2023)

Article Health Care Sciences & Services

Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT

Kim Donoghue, Sadie Boniface, Eileen Brobbin, Sarah Byford, Rachel Coleman, Simon Coulton, Edward Day, Ranjita Dhital, Anum Farid, Laura Hermann, Amy Jordan, Andreas Kimergard, Maria-Leoni Koutsou, Anne Lingford-Hughes, John Marsden, Joanne Neale, Aimee O'Neill, Thomas Phillips, James Shearer, Julia Sinclair, Joanna Smith, John Strang, John Weinman, Cate Whittlesea, Kideshini Widyaratna, Colin Drummond

Summary: This study aimed to evaluate the effectiveness of Medication Management in enhancing adherence to acamprosate. The results showed that Medication Management enhanced with Contingency Management is more beneficial for supporting patients to take acamprosate. However, there was no significant difference compared to Medication Management alone.

HEALTH TECHNOLOGY ASSESSMENT (2023)

Article Substance Abuse

A UK national study of prevalence and correlates of adopting or not adopting a recovery identity among individuals who have overcome a drug or alcohol problem

Ed Day, Ifigeneia Manitsa, Amanda Farley, John F. Kelly

Summary: Although the concept of recovery is widely used in the addiction field, many individuals with resolved alcohol or drug problems do not identify themselves as being in recovery. This is especially true for those with less severe problems and who have not engaged with formal or informal treatment systems. The understanding of recovery in the UK population studied does not align completely with abstinence from alcohol or drugs.

SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2023)

Article Psychology, Multidisciplinary

Alcohol dependence and humor styles

Julie Aitken Schermer, Marisa L. Kfrerer, Michael T. Lynskey

Summary: This study examines the relationship between alcohol dependence and humor styles, and finds a significant correlation between aggressive humor style and alcohol dependence.

CURRENT PSYCHOLOGY (2023)

Article Public, Environmental & Occupational Health

Addiction stigma and the production of impediments to take-home naloxone uptake

Renae Fomiatti, Adrian Farrugia, Suzanne Fraser, Robyn Dwyer, Joanne Neale, John Strang

Summary: Opioid overdose deaths are a significant health issue globally, including in Australia. Although there are programs to provide opioid consumers with take-home naloxone, the implementation and uptake of these programs by mainstream health services and consumers are inconsistent. Research has focused on the educational, training, and logistical obstacles to take-home naloxone distribution, but less attention has been given to the social dynamics, such as stigma, that can affect access. This article explores the role of stigma in hindering access to take-home naloxone and overdose prevention and suggests that addressing stigma is crucial for effective prevention.

HEALTH (2022)

No Data Available